Translational Research
Volume 152, Issue 6 , Pages 283-289 , December 2008

Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS)

Received 18 August 2008 ,Revised 4 October 2008 ,Accepted 6 October 2008.

References 

  1. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM. Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction. Gut. 1992;33:825–830
  2. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005;52:90–110
  3. Gue M, Del Rio-Lacheze C, Eutamene H, Theodorou V, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells. Neurogastroenterol Motil. 1997;9:271–279
  4. Yates DA, Santos J, Söderholm JD, Perdue MH. Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways. Am J Physiol Gastrointest Liver Physiol. 2001;281:124–128
  5. Ait-Belgnaoui Afifa, Bradesi Sylvie, Fioramonti Jean, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain. 2005;113:141–147
  6. Castagliuolo I, Lamont JT, Qiu B, et al. Acute stress causes mucin release from rat colon: role of corticotrophin releasing factor and mast cells. Am J Physiol. 1996;271:G884–G892
  7. Donati RJ, Rasenick MM. G protein signaling and the molecular basis of antidepressant action. Life Sciences. 2003;73:1–17
  8. Avissar S, Schreiber G. Application of G-proteins in the molecular diagnosis of psychiatric disorders. Expert Rev Mol Diagn. 2003;3:69–80
  9. Gilman AG. G proteins: transducers of receptor-generated signals. Ann Rev Biochem. 1987;56:615–649
  10. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 1995;80:249–257
  11. Nasser Y, Ho W, Sharkey KA. Distribution of adrenergic receptors in the enteric nervous system of the guinea pig, mouse, and rat. J Comp Neurol. 2006;495:529–553
  12. North RA, Surprenant A. Inhibitory synaptic potentials resulting from alpha 2-adrenoceptor activation in guinea-pig submucous plexus neurones. J Physiol. 1985;358:17–33
  13. Blandizzi C, Fornai M, Colucci R, Baschiera F, Barbara G, De Giorgio R. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2- adrenoceptors in the presence of experimental colitis. Br J Pharmacol. 2003;139:309–320
  14. Schlicker E, Gothert M. Interactions between presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurons. Brain Res Bull. 1998;47:129–132
  15. Berlioz F, Maoret JJ, Paris H, Laburthe M, Farinotti R, Rozé C. a2-Adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line. J Pharmacol Exp Ther. 2000;294:466–472
  16. Stebbing MJ, Johnson PJ, Vremec MA, Bornstein JC. Role of a2-adrenoceptors in the sympathetic inhibition of motility reflexes of guinea-pig ileum. J Physiol. 2001;534:465–478
  17. Schafermeyer A, Gratzl M, Rad R, Dossumbekova A, Sachs G, Prinz C. Isolation and receptor profiling of ileal enterochromaffin cells. Acta Physiol Scand. 2004;182:53–62
  18. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol. 1997;273:G997–G1006
  19. Burks TF. Neurotransmission and neurotransmitters. In:  Johnson LR editors. Physiology of the aastrointestinal tract. 3rd ed.. New York: Raven; 1994;p. 211–242
  20. De Ponti F, Giaroni C, Cosentino M, Lecchini S, Frigo G. Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacol Ther. 1996;69:59–78
  21. Schaak S, Cussac D, Cayla C, et al. Alpha2 adrenoceptors regulate proliferation of human intestinal epithelial cells. Gut. 2000;47:242–250
  22. Stjarne L, Stjarne E. Geometry, kinetics and plasticity of release and clearance of ATP and noradrenaline as sympathetic cotransmitters: roles for the neurogenic contraction. Prog Neurobiol. 1995;47:45–94
  23. Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem. 2006;97:310–333
  24. Williams CL, Peterson JM, Villar RG, Burks TF. Corticotropin-releasing factor directly mediates colonic responses to stress. Am J Physiol. 1987;253:G582–G586
  25. Eren I, Nazroglu M, Demirdas A, et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res. 2007;3:497–505
  26. Barone FC, Deegan JF, Price WJ, Fowler PJ, Fondacaro JD, Ormsbee HS. Cold-restraint stress increases rat fecal pellet output and colonic transit. Am J Physiol. 1990;258:G329–G337
  27. Bradesi S, Lao LJ, Mayer EA, et al. Dual role of 5-HT3 receptors in a rat model of delayed stress-induced visceral hyperalgesia. Pain. 2007;130:56–65
  28. Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain. 2005;113:141–147
  29. Yates DA, Santos J, Söderholm JD, Perdue MH. Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways. Am J Physiol. 2001;281:124–128
  30. Bennett EJ, Beaurepaire J, Langeluddecke P, Kellow J, Tennant C. Life stress and non-ulcer dyspepsia: a case-control study. J Psychosom Res. 1991;35:579–590
  31. Bennett EJ, Tennant CC, Piesse C, Badcock CA, Kellow JE. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut. 1998;43:256–261
  32. Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med. 1999;61:599–617
  33. Heitkemper M, Burr RL, Jarrett M, Hertig V, Lustyk MK, Bond EF. Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome. Dig Dis Sci. 1998;43:2093–2098
  34. Orr WC, Elsenbruch S, Harnish MJ. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome. Am J Gastroenterol. 2000;95:2865–2871
  35. Thompson JJ, Elsenbruch S, Harnish MJ, Orr WC. Autonomic functioning during REM sleep differentiates IBS symptom subgroups. Am J Gastroenterol. 2002;97:3147–3153
  36. Jennifer JT, Elsenbruch RS, Orr WC. Sleep-related autonomic disturbances in symptom subgroups of women with irritable bowel syndrome. Dig Dis Sci. 2006;51:2121–2127
  37. Laflamme T, Yannick RPT, Bourgault P, Marchand S. Different autonomic responses to sxperimental pain in IBS patients and healthy controls. J Clin Gastroenterol. 2006;40:814–820
  38. Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut. 2005;54:1396–1401
  39. Iovino P, Azpiroz F, Domingo E, Malagelada JR. The sympathetic nervous sytsem modulates perception and reflex responses to gut distension in humans. Gastroenterology. 1995;108:680–686
  40. Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, et al. Association of distinct alpha2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004;53:829–837
  41. Diatchenko L, Slade GD, Nackley AG, et al. Genetic basis for individual variations in pain perception and the development of chronic pain condition. Hum Mol Gen. 2005;14:135–143
  42. Paalzow L. Analgeisa produced by clonidine in mice and rats. J Pharm Pharmacol. 1974;26:361–363
  43. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J. Alpha-2 adrenergic transmission and human baroreflex regulation. Hypertension. 2004;43:1035–1041
  44. Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety. 2000;12:2–19
  45. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distension in humans. Am J Gastroenterol. 1997;92:2073–2079
  46. Scheibner J, Trendelenburg AU, Hein L, Starke K, Blandizzi C. alpha2-Adrenoceptors in the enteric nervous system: a study in alpha2A-adrenoceptor-deficient mice. Br J Pharmacol. 2002;135:697–704
  47. Zhu MY, Shamburger S, Li J, Ordway GA. Regulation of the human norepinephrine transporter by cocaine and amphetamine. J Pharmacol Exp Ther. 2000;295:951–959
  48. Mao W, Iwai C, Qin F, Liang CS. Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress. Am J Physiol Heart Circ Physiol. 2005;288:H2381–H2389
  49. Mao W, Qin F, Iwai C, Vulapalli R, Keng PC, Liang CS. Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells. Am J Physiol Heart Circ Physiol. 2004;287:H29–H39
  50. Sands SA, Strong R, Corbitt J, Morilak DA. Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats. Brain Res Mol Brain Res. 2000;75:1–7
  51. Tejani-Butt SM, Pare WP, Yang J. Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats. Brain Res. 1994;649:27–35
  52. Zafar HM, Pare WP, Tejani-Butt SM. Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain Res Bull. 1997;44:289–295
  53. Brooks VL, Huhtala TA, Silliman TL, Engeland WC. Water deprivation and rat adrenal mRNAs for tyrosine hydroxylase and the norepinephrine transporter. Am J Physiol. 1997;272:R1897–R1903
  54. Barkin RL, Barkin SJ. Antidepressants for the management of pain in geriatric patients. Anesth Today. 2004;15:23–26
  55. Bradley RH, Barkin RL, Jerome J, DeYoung K, Dodge CW. Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder. Am J Ther. 2003;10:318–323
  56. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5–15
  57. Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6:346–356
  58. Westanmo AD, Gayken J, Haight R. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor. Am J Health Syst Pharm. 2005;62:2481–2490

 Supported by Grant 30470795 from the National Natural Science Foundation of China.

PII: S1931-5244(08)00245-4

doi: 10.1016/j.trsl.2008.10.002

Translational Research
Volume 152, Issue 6 , Pages 283-289 , December 2008

Article Tools

* Image Usage & Resolution